Table 3.

Comparison of Lp-PLA2 Levels in the Serum Among Groups

Group	n	Lp-PLA2 (ng/mL)
Control	20	18.96±3.51
HDP	63	28.13±5.48*
GH	20	21.86±4.22**
MPE	25	27.96±5.26***
SPE	18	32.95±5.72****

Notes: *P< 0.01 compared with control group; **P< 0.05 compared with control group; ***P< 0.01 compared with GH group; ****P< 0.01 compared with MPE group.

Abbreviations: HDP, hypertensive disorders of pregnancy; GH, gestational hypertension; MPE, mild preeclampsia; SPE, severe preeclampsia.